SCHEMBL23778249

SCHEMBL23778249

CCC1CN(C2CCC(C#N)(c3cccc(Cl)c3)CC2)CCCN1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.43
DPP4 P27487 2/20 0.42
DPP8 Q6V1X1 2/20 0.42
DPP9 Q86TI2 2/20 0.42
PRKCB P05771 1/20 0.40
KDM2B Q8NHM5 2/20 0.40
CNR2 P34972 1/20 0.38
KDM1A O60341 1/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CCR2 P41597 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
SCD O00767 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23778233 0.90 CYP2D6 (0.44) CYP2D6PRKCBKDM2BKDM1AALDH1A1
SCHEMBL23778274 0.90 CYP2D6 (0.52) CYP2D6PRKCBKDM1AALDH1A1MEN1
SCHEMBL23778279 0.89 CYP2D6 (0.49) CYP2D6DPP4DPP8DPP9PRKCB
SCHEMBL23778310 0.89 CYP2D6 (0.46) CYP2D6PRKCBKDM1AKMT2ACCR2
SCHEMBL23778436 0.84 CYP2D6 (0.41) CYP2D6PRKCBKDM2B
SCHEMBL23778231 0.83 CYP2D6 (0.44) CYP2D6DPP4DPP8DPP9PRKCB
SCHEMBL23778336 0.83 CYP2D6 (0.57) CYP2D6PRKCBKDM1AALDH1A1PDE4A
SCHEMBL23778427 0.82 CYP2D6 (0.48) CYP2D6KDM1AALDH1A1MEN1KMT2A
SCHEMBL23778283 0.82 CYP2D6 (0.44) CYP2D6KDM2BCNR2ALDH1A1LMNA
SCHEMBL23778252 0.81 DPP4 (0.38) CYP2D6DPP4PRKCBKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP claimed